Evidence map›Paper›PMID 35893710›Full record

ArticlePharmacy (Basel, Switzerland)2022

Mobile-Based Augmented Reality Application in Pharmacy Schools Implemented in Pharmaceutical Compounding Laboratories: Students' Benefits and Reception.

Mohamed Ismail Nounou, Heba A Eassa, Kamila Orzechowski, Hadeer A Eassa, Jerry Edouard, Nicole Stepak, Mohammad Khdeer, Mohammed Kalam, Diana Huynh, Eric Kwarteng and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mohamed Ismail NounouDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Heba A EassaDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.ORCID 0000-0001-8888-3749
Kamila OrzechowskiDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Hadeer A EassaDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Jerry EdouardDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Nicole StepakDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Mohammad KhdeerDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Mohammed KalamDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Diana HuynhDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Eric KwartengEric Kwarteng, PHARMD, Rph, Oncology Pharmacist, Stamford Hospital, Hospital Plaza, Stamford, CT 06902, USA.
Kamilia H A MohamedFaculty of Pharmacy (Girls), Al-Azhar University, Nasr City, Cairo 11657, Egypt.
Nada A HelalIrma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, 310 Reynolds Medical Sciences Building, Kingsville, TX 77843, USA.
Nehal A AhmedSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, 1800 Bienville Drive, University of Louisiana at Monroe, Monroe, LA 71201, USA.
Ivan O EdafioghoDepartment of Pharmaceutical Sciences, School of Pharmacy and Physician Assistant Studies, University of St. Joseph, Hartford, CT 06103, USA.
Ola GhoneimDepartment of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA 01119, USA.ORCID 0000-0002-2820-3972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAugmented reality (AR) is a technological approach which combines virtual objects such as text, pictures or videos with physical objects (real-world). The study aimed to design, implement and validate a mobile-based AR application, as a self-paced, interactive, student-centered learning tool be used in the pharmaceutical compounding laboratory course for first year pharmacy students.

methodA mobile-based AR application (Amplified Rx app; HeyPayLess Inc) compatible with iOS and android operating system was developed. A cross-over study design was conducted where alternatively, one group was subjected to ARx app implementation in 8 formulations and the other group served as control. The reception and benefits to students were assessed via a 10 questions survey. In this case, 69 (2019) and 55 (2020) students participated in the study.

resultStudents' use of ARx app was increased in 2020 which indicates its usefulness. For acceptability, leaners enjoyed interactive materials and tutorial videos were the most used and appealing item. Learners described the installation, scanning and operation to be very easy in both years. 86.95% of learners were confident conducting the experiments with the assistance of ARx app in 2019 and increased to 92.73% in 2020. 33.33% considered ARx app to be the most helpful resource in 2019, and the percent was significantly increased to 76.36% in 2020.

conclusionAR technology implementation in pharmaceutical education could create student-centered engaging and interactive learning experience in fundamental areas such as pharmaceutical compounding laboratories.

Indexed as

augmented realitypharmaceutical compoundingpharmacy educationstudent-centered learning

Identifiers

PMID35893710
PMCPMC9326741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.